Default company panoramic image


CureLauncher solves the clinical trial enrollment and funding problem for new treatments. It empowers people to fight disease.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location Bloomfield Hills, MI, USA
  • Currency USD
  • Founded August 2012
  • Employees 7
  • Website

Company Summary

CureLauncher solves the clinical trial enrollment and funding problem for new treatments. Delays in patient recruiting account for 4.6 months lost per trial; over 50,000 trials per year. Lack of funding inhibits 8,000 NIH funded private companies from advancing their treatments. CureLauncher initial customers are the 12 Million Americans with cancer history and 1.6 Million new cases per year. CureLauncher empowers people to fight disease.


  • Default avatar
    Stephen Jeffrey Goldner

    Mr. Goldner is a forensic toxicologist and regulatory attorney. He developed oral liquid dose Methadone and launched Mifflin Pharma. He also developed the lab methods for drug abuse screening and launched Spectrum Labs. He has gotten 230 medical devices and drugs approved at FDA, facilitating the start up of over 200 companies. Steve also serves on University of Michigan funding committees for new technologies and advises NIH on FDA issues.

  • Default avatar
    David Craig Fuehrer
    Vice President

    Mr. Fuehrer is an innovation specialist. He has spent the past 10 years managing innovation and market entry programs for Pfizer, General Electric, Dow Solar and many others. Mr. Fuehrer has an MBA in technology management and has completed Executive Education at Harvard in Building New Ventures and at MIT in Corporate Strategy.


  • Default avatar
    Steven Cole, Lipson, Cole, Seltzer & Garvin
    Default avatar
    Gary Kushner, Kushner, Kippleman and Taub

Previous Investors

  • Default avatar
    Stephen Goldner